Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
SALBUTAMOL SULFATE
Innovata Biomed Ltd
95mcg/actu %v/v
Powder for Inhalation
1998-04-17
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0486/001/001 Case No: 2029180 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to INNOVATA BIOMED LTD 1 MERE WAY, RUDDINGTON, NOTTINGHAM, NG11 6JS, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product CLICKHALER SALBUTAMOL INHALATION POWDER, 95 MICROGRAMS/INHALATION The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 27/08/2008. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 29/09/2008_ _CRN 2029180_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clickhaler Salbutamol inhalation powder, 95 micrograms/inhalation 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each metered actuation of 3 mg of inhalation powder contains 114 micrograms of salbutamol sulphate (95 micrograms salbutamol base) and delivers 110 micrograms of salbutamol sulphate (90 micrograms of salbutamol base). For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Inhalation powder. A plastic inhaler device incorporating an actuating and metering mechanism enclosed within an aluminium foil heat sealed bag. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cli Read the complete document